CordenPharma targets 500m injectable units with €80m expansion

CordenPharma is investing €80m to significantly expand its manufacturing capacity for sterile injectable medicines in Italy. Once completed, the site will be ab...

Marie Gårdmark: Are FDA and EMA drifting apart?

Are FDA and EMA beginning to drift apart on what it takes to approve new medicines? And what could that mean for drug development on both sides of the Atlantic?...

How SweTrial aims to bring more clinical trials to Sweden

Sweden has lost ground in clinical trials. SweTrial now aims to reverse the trend, but both the Swedish Medical Products Agency and the pharmaceutical industry ...

Artisan Partners demands board changes at Novartis after share-price plunge

Artisan Partners, one of Novartis’ 20 largest shareholders, is demanding changes to the pharmaceutical company’s board and tighter oversight of acquisitions aft...

Breakthroughs in narcolepsy recognized by Lasker Awards

This year’s Lasker Awards are presented to researchers behind discoveries that have led to breakthroughs in narcolepsy and hemophilia – and to one of Hollywood’...

Novonesis to invest €600 million in India factory

Danish biosolutions manufacturer Novonesis has decided to invest massively in its Indian factory.

Sobi gains regulatory momentum with new FDA Fast Track designation

Sobi has secured a US FDA Fast Track designation for pacritinib, advancing the drug’s development as a potential treatment for the rare and severe autoinflammat...

AddLife adds new company to its portfolio

The Swedish life science group AddLife has acquired Unicam Sistemas Analíticos, a Portuguese distributor of advanced analytical laboratory equipment.

Denmark a leader in EU clinical trials: “We should never accept unnecessary delays”

A principal of quick processing as well as engaging in ongoing dialogue with sponsors has helped Denmark to lead EU in clinical trials.

Elizabeth Schepke named Childhood cancer researcher of the Year 2026

Oncologist Elizabeth Schepke has been named Childhood Cancer Researcher of the Year 2026 by the Swedish Childhood Cancer Foundation.

Bangladesh was close to eliminating measles – now it has the world’s largest outbreak

Bangladesh was close to eliminating measles. Now the country is battling the world’s largest outbreak, with more than 166,000 suspected cases and nearly 1,000 r...

SmartCella secures key patents in the US and Japan

Swedish drug-delivery company SmartCella has secured the main patent for its Extroducer device in the US and Japan, completing global protection following the E...

Regulatory milestone strengthens Xinnate’s EB program

Xinnate has received a notification from the U.S. Food and Drug Administration (FDA) that may bring significant advantages in the development of the company’s t...

Nordic newcomer on an acquisition drive – snaps up four Swedish distributors

Over the past five years, Medu Group has built a Nordic distribution business. “We aim to become one of the major Nordic distributors in medtech,” says Magnus S...

Turning insights into impact

Explore the ZEISS INNOVATION SUMMIT 2026.

Novo Nordisk Pharmatech CEO to step down

Ulla Grove Krogsgaard Thomsen has decided to leave Novo Nordisk Pharmatech to pursue af different career.

Novartis hit by another major setback – shares plunge

Novartis has suffered another major pipeline setback. A key drug candidate acquired through its $12bn takeover of Avidity has failed in phase III, sending the c...

BII injects fresh millions into six ‘promising’ Danish startups

BioInnovation Institute (BII) is allocating new convertible loans of EUR 1.3 million to six Danish startups previously backed by the organisation.

Political consensus on how to bring more new medicines to Sweden

Sweden is losing ground when it comes to access to new medicines. Ahead of the election, the country’s parliamentary parties are unusually united on what needs ...

Novo Nordisk halts two more heart drug trials

Novo Nordisk is discontinuing two Phase III trials of its drug candidate ziltivekimab in heart failure and inflammation.

Four in ten children shed obesity in Novo trial

A phase III study testing semaglutide in children with obesity met its primary endpoint, Novo Nordisk reports.

IVDR - From Fundamentals to Technical Documentation – Get Ready for Certification

The EU IVDR Regulation has significantly changed the requirements for in vitro diagnostic (IVD) medical devices. IVDR (EU 2017/746) replaces the former IVDD Dir...

IVDR - From Fundamentals to Technical Documentation – Get Ready for Certification

On-demand webinar: ZEISS Lightfield 4D for high-content tumor microtissue screening

From reliable and scalable 3D models to quantitative insights.